Shanghai Institute of Materia Medica, Chinese Academy of Sciences;Topharman Shanghai Co., Ltd.
发明人:
申请号：
EP18846464.8
公开号：
EP3670511A1
申请日:
2018.08.14
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
The present invention provides a tetrahydroprotoberberine compound represented by the formula (I), enantiomers, diastereomers, racemates and mixtures thereof, and pharmaceutically acceptable salts, crystalline hydrates and solvates thereof. The invention also provides a method for preparing the compound and the use thereof in the preparation of a medicament for preventing and/or treating central nervous system diseases.
